€0.00
The RESOMER® and LACTEL® portfolios provide an industry-leading selection of functional excipients for parenteral controlled release.
Both portfolios are 100% bioresorbable, completely metabolized by the body, and ideal for terminal sterilization. Both RESOMER® and LACTEL® have long stability supported by data and are highly suitable for use with small molecules, peptides, proteins and other substances. Both are supplied from modern, established manufacturing sites in the U.S. and Germany – ensuring extensive options for dual sourcing and supply security.
LACTEL® broad standard catalog of unpurified bioresorbable polymers
The standard LACTEL® portfolio boasts of more than 20 standard polymers available as a
cost effective supply due to streamlined manufacturing processes. Common application areas
for LACTEL® standard polymers include veterinary medicine, where bioresorbable polymers
are used in long-acting injectable formulations, and human generic drug formulations, which
require price-sensitive planning and quick shipment to support demanding, fast-paced markets.
| Manufacturer |
Evonik Operations GmbH |
|---|---|
| Composition |
Poly(D,L-lactide), Poly(DL-lactide-co-glycolide) |
| Dosage Form |
Parenteral |
| Function |
100% bioresorbable, completely metabolized by the body, and ideal for terminal sterilization, long stability, long-acting injectable formulations, parenteral controlled release |
